All AbMole products are for research use only, cannot be used for human consumption.
Nicotinamide is an active component of coenzymes NAD and NADP, and also act as an inhibitor of sirtuins. Nicotinamide plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions.
Cancer Lett. 2024 Oct 02;605:217284.
Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer
Nicotinamide purchased from AbMole
FEBS J. 2024 Sep 09.
MOF-mediated acetylation of CDK9 promotes global transcription by modulating P-TEFb complex formation
Nicotinamide purchased from AbMole
J Cancer. 2024 Jun 22.
Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway
Nicotinamide purchased from AbMole
Cell Stem Cell. 2020 Nov 5;27(5):840-851.e6.
Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo
Nicotinamide purchased from AbMole
Sci Rep. 2020 Jul 31;10(1):12991.
Mutation accumulation and developmental lineages in normal and Down syndrome human fetal haematopoiesis
Nicotinamide purchased from AbMole
| Molecular Weight | 122.12 |
| Formula | C6H6N2O |
| CAS Number | 98-92-0 |
| Solubility (25°C) | DMSO 30 mg/mL Water 30 mg/mL |
| Storage | -20°C, protect from light, sealed |
[1] Mario Mehmel, et al. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses
[3] Luca Fania, et al. Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention
[5] Frances M Walocko, et al. The role of nicotinamide in acne treatment
| Related Sirtuin Products |
|---|
| SIRT1-IN-1
SIRT1-IN-1 is a selective SIRT1 inhibitor with an IC50 of 0.205 μM. |
| Sirtuin-1 inhibitor 1
Sirtuin-1 inhibitor 1 is an inhibitor of Sirtuin-1 that plays important roles in obesity-induced diabetes and aging-related diseases. |
| ADTL-SA1215
ADTL-SA1215 is a first-in-class, specific small molecule activator of SIRT3 that modulates autophagy in triple-negative breast cancer. |
| SIRT2/6-IN-1
SIRT2/6-IN-1 is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. |
| SIRT6-IN-2
SIRT6-IN-2 is a selective SIRT6 inhibitor (IC50: 34 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
